| WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ... Oncogene 38 (21), 4047-4060, 2019 | 117 | 2019 |
| Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection S Petta, C Camma, VD Marco, FS Macaluso, M Maida, G Pizzolanti, ... Liver International 31 (4), 507-515, 2011 | 109 | 2011 |
| Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications F Tedesco, MO Borghi, M Gerosa, CB Chighizola, P Macor, PA Lonati, ... Frontiers in Immunology 9, 1388, 2018 | 41 | 2018 |
| Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate CancerMast Cells Foster Tumor Immune Suppression E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ... Cancer immunology research 6 (5), 552-565, 2018 | 38 | 2018 |
| Complement protein C1q binds to hyaluronic acid in the malignant pleural mesothelioma microenvironment and promotes tumor growth C Agostinis, R Vidergar, B Belmonte, A Mangogna, L Amadio, P Geri, ... Frontiers in immunology 8, 1559, 2017 | 32 | 2017 |
| New landscapes and horizons in hepatocellular carcinoma therapy M Cervello, MR Emma, G Augello, A Cusimano, L Giannitrapani, M Soresi, ... Aging (Albany NY) 12 (3), 3053, 2020 | 31 | 2020 |
| Is the complement protein C1q a pro-or anti-tumorigenic factor? Bioinformatics analysis involving human carcinomas A Mangogna, C Agostinis, D Bonazza, B Belmonte, P Zacchi, G Zito, ... Frontiers in immunology 10, 865, 2019 | 29 | 2019 |
| Prognostic implications of the complement protein C1q in gliomas A Mangogna, B Belmonte, C Agostinis, P Zacchi, DG Iacopino, ... Frontiers in immunology, 2366, 2019 | 27 | 2019 |
| Evaluation of thermoresponsive properties and biocompatibility of polybenzofulvene aggregates for leuprolide delivery M Licciardi, G Amato, A Cappelli, M Paolino, G Giuliani, B Belmonte, ... International journal of pharmaceutics 438 (1-2), 279-286, 2012 | 27 | 2012 |
| Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma G Augello, MR Emma, A Cusimano, A Azzolina, S Mongiovì, R Puleio, ... International journal of cancer 144 (10), 2613-2624, 2019 | 26 | 2019 |
| Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis F Colombo, P Durigutto, L De Maso, S Biffi, B Belmonte, C Tripodo, ... Journal of Autoimmunity 103, 102288, 2019 | 20 | 2019 |
| Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients E Ferretti, S Hohaus, A Di Napoli, B Belmonte, A Cuccaro, E Cupelli, ... Oncotarget 8 (49), 85263, 2017 | 19 | 2017 |
| Pathological significance and prognostic value of surfactant protein D in cancer A Mangogna, B Belmonte, C Agostinis, G Ricci, A Gulino, I Ferrara, ... Frontiers in Immunology 9, 1748, 2018 | 18 | 2018 |
| The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer L Forte, F Turdo, C Ghirelli, P Aiello, P Casalini, MV Iorio, E D’Ippolito, ... BMC cancer 18 (1), 1-11, 2018 | 15 | 2018 |
| Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerImplication of Gut Microbes in Response to Trastuzumab Therapy M Di Modica, G Gargari, V Regondi, A Bonizzi, S Arioli, B Belmonte, ... Cancer Research 81 (8), 2195-2206, 2021 | 14 | 2021 |
| Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells MC Anania, E Cetti, D Lecis, K Todoerti, A Gulino, G Mauro, T Di Marco, ... Cancer letters 410, 201-211, 2017 | 14 | 2017 |
| Biocompatibility and biodegradability of electrospun PHEA-PLA scaffolds: our preliminary experience in a murine animal model AI Lo Monte, M Licciardi, M Bellavia, G Damiano, VD Palumbo, ... Digest Journal of Nanomaterials and Biostructures 7 (2), 841-851, 2012 | 14 | 2012 |
| CD10 and HHF35 actin in the differential diagnosis between Collagenous spherulosis and adenoid-cystic carcinoma of the breast D Cabibi, AG Giannone, B Belmonte, F Aragona, F Aragona Pathology-Research and Practice 208 (7), 405-409, 2012 | 12 | 2012 |
| Cross-talk between myeloid-derived suppressor cells and mast cells mediates tumor-specific immunosuppression in prostate cancer. Cancer Immunol. Res. 2018; 6: 552–565. doi: 10 … E Jachetti, V Cancila, A Rigoni, L Bongiovanni, B Cappetti, B Belmonte, ... CIR-17-0385, 0 | 10 | |
| Hyaluronic acid present in the tumor microenvironment can negate the pro-apototic effect of a recombinant fragment of human surfactant protein D on breast cancer cells V Murugaiah, C Agostinis, PM Varghese, B Belmonte, S Vieni, FA Alaql, ... Frontiers in Immunology 11, 1171, 2020 | 9 | 2020 |
